Data:
{
"symbol": "ARQT",
"price": 25.195,
"marketCap": 3151466185,
"beta": 1.526,
"lastDividend": 0,
"range": "15.1-31.77",
"change": -1.265,
"changePercentage": -4.7808,
"volume": 1589619,
"averageVolume": 1678796,
"companyName": "Arcutis Biotherapeutics, Inc.",
"currency": "USD",
"cik": "0001787306",
"isin": "US03969K1088",
"cusip": "03969K108",
"exchangeFullName": "NASDAQ Global Select",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://www.arcutis.com",
"description": "Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.",
"ceo": "Todd Franklin Watanabe",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "354",
"phone": "805 418 5006",
"address": "3027 Townsgate Road",
"city": "Westlake Village",
"state": "CA",
"zip": "91361",
"image": "https://images.financialmodelingprep.com/symbol/ARQT.png",
"ipoDate": "2020-01-31",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "ARQT",
"name": "Arcutis Biotherapeutics, Inc.",
"price": 25.195,
"changePercentage": -4.7808,
"change": -1.265,
"volume": 1589287.23413,
"dayLow": 24.8802,
"dayHigh": 26.56,
"yearHigh": 31.77,
"yearLow": 15.1,
"marketCap": 3151466185,
"priceAvg50": 26.6236,
"priceAvg200": 25.6048,
"exchange": "NASDAQ",
"open": 26.49,
"previousClose": 26.46,
"timestamp": 1787244303,
"chart_vwap_daily": [
{
"t": "2026-07-10",
"v": 27.5932,
"c": 27.74
},
{
"t": "2026-07-13",
"v": 27.0113,
"c": 27.12
},
{
"t": "2026-07-14",
"v": 26.8559,
"c": 26.81
},
{
"t": "2026-07-15",
"v": 27.6459,
"c": 27.78
},
{
"t": "2026-07-16",
"v": 27.6878,
"c": 27.74
},
{
"t": "2026-07-17",
"v": 28.4283,
"c": 28.49
},
{
"t": "2026-07-20",
"v": 27.8037,
"c": 27.53
},
{
"t": "2026-07-21",
"v": 28.1197,
"c": 28.26
},
{
"t": "2026-07-22",
"v": 27.9195,
"c": 27.9
},
{
"t": "2026-07-23",
"v": 27.3586,
"c": 27.33
},
{
"t": "2026-07-24",
"v": 27.2917,
"c": 27.35
},
{
"t": "2026-07-27",
"v": 28.0023,
"c": 27.84
},
{
"t": "2026-07-28",
"v": 28.2509,
"c": 28.42
},
{
"t": "2026-07-29",
"v": 28.0129,
"c": 27.86
},
{
"t": "2026-07-30",
"v": 27.9446,
"c": 27.99
},
{
"t": "2026-07-31",
"v": 26.7945,
"c": 26.86
},
{
"t": "2026-08-03",
"v": 26.0101,
"c": 25.94
},
{
"t": "2026-08-04",
"v": 26.0553,
"c": 26.03
},
{
"t": "2026-08-05",
"v": 26.9727,
"c": 27.1
},
{
"t": "2026-08-06",
"v": 26.9632,
"c": 26.43
},
{
"t": "2026-08-07",
"v": 25.6198,
"c": 25.29
},
{
"t": "2026-08-10",
"v": 25.6974,
"c": 25.92
},
{
"t": "2026-08-11",
"v": 26.399,
"c": 26.23
},
{
"t": "2026-08-12",
"v": 26.1886,
"c": 26.28
},
{
"t": "2026-08-13",
"v": 25.9509,
"c": 25.83
},
{
"t": "2026-08-14",
"v": 25.9051,
"c": 26.19
},
{
"t": "2026-08-17",
"v": 25.7824,
"c": 25.61
},
{
"t": "2026-08-18",
"v": 26.3143,
"c": 26.54
},
{
"t": "2026-08-19",
"v": 26.6049,
"c": 26.46
},
{
"t": "2026-08-20",
"v": 25.1802,
"c": 25.185
}
],
"vwap_summary": {
"days": 30,
"days_above": 16,
"days_below": 14,
"pct_days_above": 53,
"position": "above",
"gap_pct": 0.02,
"streak_days": 1
}
}
Data:
{
"volume": 1589287.23413,
"avgVolume": 1678796,
"short_ratio": [
{
"symbol": "ARQT",
"file_date": "2026-08-19",
"date": "20260819",
"short_volume": 144613,
"short_exempt_volume": 0,
"total_volume": 278787,
"short_volume_ratio": 0.5187,
"signal": "Neutral"
}
],
"volume_profile": {
"poc": 26.06,
"vah": 26.97,
"val": 25.47,
"profile": [
{
"price": 25.0,
"volume": 243160
},
{
"price": 25.07,
"volume": 606681
},
{
"price": 25.13,
"volume": 218784
},
{
"price": 25.19,
"volume": 128327
},
{
"price": 25.25,
"volume": 189516
},
{
"price": 25.32,
"volume": 117028
},
{
"price": 25.38,
"volume": 567132
},
{
"price": 25.44,
"volume": 219719
},
{
"price": 25.5,
"volume": 485258
},
{
"price": 25.57,
"volume": 407195
},
{
"price": 25.63,
"volume": 622992
},
{
"price": 25.69,
"volume": 606100
},
{
"price": 25.75,
"volume": 336661
},
{
"price": 25.81,
"volume": 590633
},
{
"price": 25.88,
"volume": 994573
},
{
"price": 25.94,
"volume": 958214
},
{
"price": 26.0,
"volume": 1172802
},
{
"price": 26.06,
"volume": 1188399
},
{
"price": 26.13,
"volume": 575164
},
{
"price": 26.19,
"volume": 769329
},
{
"price": 26.25,
"volume": 873744
},
{
"price": 26.31,
"volume": 327902
},
{
"price": 26.38,
"volume": 792738
},
{
"price": 26.44,
"volume": 747997
},
{
"price": 26.5,
"volume": 950274
},
{
"price": 26.56,
"volume": 625901
},
{
"price": 26.63,
"volume": 531997
},
{
"price": 26.69,
"volume": 519778
},
{
"price": 26.75,
"volume": 433941
},
{
"price": 26.81,
"volume": 342500
},
{
"price": 26.87,
"volume": 952205
},
{
"price": 26.94,
"volume": 697050
},
{
"price": 27.0,
"volume": 220755
},
{
"price": 27.06,
"volume": 94791
},
{
"price": 27.12,
"volume": 31716
},
{
"price": 27.19,
"volume": 180615
},
{
"price": 27.25,
"volume": 43056
},
{
"price": 27.31,
"volume": 273748
},
{
"price": 27.37,
"volume": 56148
},
{
"price": 27.44,
"volume": 70079
},
{
"price": 27.5,
"volume": 44885
},
{
"price": 27.56,
"volume": 25682
},
{
"price": 27.62,
"volume": 45394
},
{
"price": 27.68,
"volume": 24885
},
{
"price": 27.75,
"volume": 375656
},
{
"price": 27.81,
"volume": 199452
},
{
"price": 27.87,
"volume": 424200
},
{
"price": 27.93,
"volume": 318744
},
{
"price": 28.0,
"volume": 329025
},
{
"price": 28.06,
"volume": 302676
},
{
"price": 28.12,
"volume": 187379
},
{
"price": 28.18,
"volume": 252196
},
{
"price": 28.25,
"volume": 119720
},
{
"price": 28.31,
"volume": 154164
},
{
"price": 28.37,
"volume": 240146
},
{
"price": 28.43,
"volume": 363218
},
{
"price": 28.5,
"volume": 191200
},
{
"price": 28.56,
"volume": 25598
},
{
"price": 28.62,
"volume": 0
},
{
"price": 28.68,
"volume": 63899
}
],
"sessions": 20
}
}
Data:
{
"symbol": "ARQT",
"marketCap": 3151466185,
"enterpriseValueTTM": 3230856770,
"evToSalesTTM": 6.964686452678019,
"evToOperatingCashFlowTTM": 82.20718372382915,
"evToFreeCashFlowTTM": 82.53894370514163,
"evToEBITDATTM": 73.2280854993315,
"netDebtToEBITDATTM": 1.8132293956355232,
"currentRatioTTM": 2.9167456654608954,
"incomeQualityTTM": 1.3783442617202566,
"grahamNumberTTM": 2.8824167145530444,
"grahamNetNetTTM": 0.8152265518456658,
"taxBurdenTTM": 0.9734111543450065,
"interestBurdenTTM": 0.7114791519949489,
"workingCapitalTTM": 307331000,
"investedCapitalTTM": 326143000,
"returnOnAssetsTTM": 0.058376335876300055,
"operatingReturnOnAssetsTTM": 0.07222257363948806,
"returnOnTangibleAssetsTTM": 0.06005896598925976,
"returnOnEquityTTM": 0.1505399331467354,
"returnOnInvestedCapitalTTM": 0.09948545644084389,
"returnOnCapitalEmployedTTM": 0.10436719409379124,
"earningsYieldTTM": 0.008672338292995121,
"freeCashFlowYieldTTM": 0.012423106484958207,
"capexToOperatingCashFlowTTM": 0.004019435752626625,
"capexToDepreciationTTM": 0.07022222222222223,
"capexToRevenueTTM": 0.00034053118554423567,
"salesGeneralAndAdministrativeToRevenueTTM": 0.6413947984939038,
"researchAndDevelopementToRevenueTTM": 0.19620846543285178,
"stockBasedCompensationToRevenueTTM": 0.09385944683079694,
"intangiblesToTotalAssetsTTM": 0.028016301733543213,
"averageReceivablesTTM": 149769500,
"averagePayablesTTM": 12450000,
"averageInventoryTTM": 38135000,
"daysOfSalesOutstandingTTM": 122.06131285548331,
"daysOfPayablesOutstandingTTM": 58.65437025501265,
"daysOfInventoryOutstandingTTM": 345.3093975082733,
"operatingCycleTTM": 467.37071036375664,
"cashConversionCycleTTM": 408.716340108744,
"freeCashFlowToEquityTTM": 39151000,
"freeCashFlowToFirmTTM": 52628850.843060955,
"tangibleAssetValueTTM": 206892000,
"netCurrentAssetValueTTM": 199713000,
"grossProfitMarginTTM": 0.9114274075878107,
"ebitMarginTTM": 0.08875147904763342,
"ebitdaMarginTTM": 0.09510949801823781,
"operatingProfitMarginTTM": 0.07382414366105508,
"pretaxProfitMarginTTM": 0.0631448270511077,
"continuousOperationsProfitMarginTTM": 0.06146587899073454,
"netProfitMarginTTM": 0.06146587899073454,
"bottomLineProfitMarginTTM": 0.06146587899073454,
"receivablesTurnoverTTM": 2.9903004601642156,
"payablesTurnoverTTM": 6.222895215021199,
"inventoryTurnoverTTM": 1.0570230715810591,
"fixedAssetTurnoverTTM": 90.53287804878049,
"assetTurnoverTTM": 0.949735639265808,
"quickRatioTTM": 2.674267182237745,
"solvencyRatioTTM": 0.11744004657446316,
"cashRatioTTM": 0.2128040414119995,
"priceToEarningsRatioTTM": 114.08514492753623,
"priceToEarningsGrowthRatioTTM": 0.018671614918081492,
"forwardPriceToEarningsGrowthRatioTTM": 0.5253497304829305,
"priceToEarningsDilutedRatioTTM": 120.81534772182253,
"priceToEarningsDilutedGrowthRatioTTM": 0.03294478176439847,
"priceToBookRatioTTM": 14.905540327955062,
"priceToSalesRatioTTM": 6.7908831827165335,
"priceToFreeCashFlowRatioTTM": 80.47919005900232,
"priceToOperatingCashFlowRatioTTM": 83.64113002111476,
"debtToAssetsRatioTTM": 0.23363020610516705,
"debtToEquityRatioTTM": 0.5174427302689739,
"debtToCapitalRatioTTM": 0.3409965463258404,
"longTermDebtToCapitalRatioTTM": 0.31609560690666577,
"financialLeverageRatioTTM": 2.214793792700121,
"workingCapitalTurnoverRatioTTM": 1.5939325024390913,
"operatingCashFlowRatioTTM": 0.24516028439565923,
"operatingCashFlowSalesRatioTTM": 0.08472114159847062,
"freeCashFlowOperatingCashFlowRatioTTM": 0.9959805642473734,
"debtServiceCoverageRatioTTM": 2.084535487593768,
"interestCoverageRatioTTM": 2.473855265058501,
"shortTermOperatingCashFlowCoverageRatioTTM": 5.655971223021583,
"operatingCashFlowCoverageRatioTTM": 0.34440190297624784,
"capitalExpenditureCoverageRatioTTM": 248.79113924050634,
"dividendPaidAndCapexCoverageRatioTTM": 248.79113924050634,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 3.5548106832564623,
"netIncomePerShareTTM": 0.21849956329201206,
"interestDebtPerShareTTM": 0.9805473406781998,
"cashPerShareTTM": 1.8276765602733638,
"bookValuePerShareTTM": 1.6899756362912,
"tangibleBookValuePerShareTTM": 1.5851120883835674,
"shareholdersEquityPerShareTTM": 1.6899756362912,
"operatingCashFlowPerShareTTM": 0.30116761925192687,
"capexPerShareTTM": 0.0012105238963546375,
"freeCashFlowPerShareTTM": 0.29995709535557225,
"netIncomePerEBTTTM": 0.9734111543450065,
"ebtPerEbitTTM": 0.8553411380025108,
"priceToFairValueTTM": 14.905540327955062,
"debtToMarketCapTTM": 0.03456220353528052,
"effectiveTaxRateTTM": 0.026588845654993514,
"enterpriseValueMultipleTTM": 73.21391307303587,
"dividendPerShareTTM": 0,
"revenue_history": [
{
"date": "2025",
"revenue": 376072000
}
],
"dcf": {
"symbol": "ARQT",
"date": "2026-08-20",
"dcf": -170.73855158958116,
"Stock Price": 26.46
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "ARQT",
"reportedCurrency": "USD",
"cik": "0001787306",
"filingDate": "2026-02-25",
"acceptedDate": "2026-02-25 16:07:47",
"fiscalYear": "2025",
"period": "FY",
"revenue": 376072000,
"costOfRevenue": 36695000,
"grossProfit": 339377000,
"researchAndDevelopmentExpenses": 77051000,
"generalAndAdministrativeExpenses": 0,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 274553000,
"otherExpenses": 0,
"operatingExpenses": 351604000,
"costAndExpenses": 388299000,
"netInterestIncome": -12083000,
"interestIncome": 0,
"interestExpense": 12083000,
"depreciationAndAmortization": 5367000,
"ebitda": 2480000,
"ebit": -2887000,
"nonOperatingIncomeExcludingInterest": -9340000,
"operatingIncome": -12227000,
"totalOtherIncomeExpensesNet": -2743000,
"incomeBeforeTax": -14970000,
"incomeTaxExpense": 1171000,
"netIncomeFromContinuingOperations": -16141000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": -16140999,
"netIncomeDeductions": 0,
"bottomLineNetIncome": -16140999,
"eps": -0.13,
"epsDiluted": -0.13,
"weightedAverageShsOut": 127234000,
"weightedAverageShsOutDil": 127234000
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "ARQT",
"reportedCurrency": "USD",
"cik": "0001787306",
"filingDate": "2026-02-25",
"acceptedDate": "2026-02-25 16:07:47",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 42907000,
"shortTermInvestments": 178075000,
"cashAndShortTermInvestments": 220982000,
"netReceivables": 146229000,
"accountsReceivables": 146229000,
"otherReceivables": 0,
"inventory": 22634000,
"prepaids": 11594000,
"otherCurrentAssets": 9793000,
"totalCurrentAssets": 411232000,
"propertyPlantEquipmentNet": 5510000,
"goodwill": 0,
"intangibleAssets": 14812000,
"goodwillAndIntangibleAssets": 14812000,
"longTermInvestments": 0,
"taxAssets": 0,
"otherNonCurrentAssets": 1419000,
"totalNonCurrentAssets": 21741000,
"otherAssets": 0,
"totalAssets": 432973000,
"totalPayables": 12528000,
"accountPayables": 12528000,
"otherPayables": 0,
"accruedExpenses": 0,
"shortTermDebt": 1000000,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 0,
"deferredRevenue": 0,
"otherCurrentLiabilities": 116310000,
"totalCurrentLiabilities": 129838000,
"longTermDebt": 5266000,
"capitalLeaseObligationsNonCurrent": 0,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 0,
"otherNonCurrentLiabilities": 108390000,
"totalNonCurrentLiabilities": 113656000,
"otherLiabilities": 0,
"capitalLeaseObligations": 0,
"totalLiabilities": 243494000,
"treasuryStock": 0,
"preferredStock": 0,
"commonStock": 12000,
"retainedEarnings": -1138084000,
"additionalPaidInCapital": 1327595000,
"accumulatedOtherComprehensiveIncomeLoss": -44000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 189479000,
"totalEquity": 189479000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 432973000,
"totalInvestments": 178075000,
"totalDebt": 6266000,
"netDebt": -36641000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "ARQT",
"reportedCurrency": "USD",
"cik": "0001787306",
"filingDate": "2026-02-25",
"acceptedDate": "2026-02-25 16:07:47",
"fiscalYear": "2025",
"period": "FY",
"netIncome": -16141000,
"depreciationAndAmortization": 4667000,
"deferredIncomeTax": 0,
"stockBasedCompensation": 40364000,
"changeInWorkingCapital": -34829000,
"accountsReceivables": -73163000,
"inventory": -7329000,
"accountsPayables": -1694000,
"otherWorkingCapital": 47357000,
"otherNonCashItems": 314000,
"netCashProvidedByOperatingActivities": -5625000,
"investmentsInPropertyPlantAndEquipment": -686000,
"acquisitionsNet": 0,
"purchasesOfInvestments": -246986000,
"salesMaturitiesOfInvestments": 227419000,
"otherInvestingActivities": -10000000,
"netCashProvidedByInvestingActivities": -30253000,
"netDebtIssuance": 0,
"longTermNetDebtIssuance": 0,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": 6973000,
"netCommonStockIssuance": 6973000,
"commonStockIssuance": 6973000,
"commonStockRepurchased": 0,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": 0,
"netCashProvidedByFinancingActivities": 6973000,
"effectOfForexChangesOnCash": 168000,
"netChangeInCash": -28737000,
"cashAtEndOfPeriod": 43215000,
"cashAtBeginningOfPeriod": 71952000,
"operatingCashFlow": -5625000,
"capitalExpenditure": -686000,
"freeCashFlow": -6311000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 25.135,
"rsi": 41.89070670634554,
"sma20": 26.565250000000002,
"sma50": 26.6705,
"sma200": 25.603974999999995,
"adx": 18.204296466677196,
"atr": 1.2,
"atr_pct": 4.77,
"atr_expansion_pct": 1.5,
"di_plus": 27.7,
"di_minus": 25.6,
"high_52w": 31.2,
"low_52w": 14.19,
"structure": {
"ema8": 25.9994319271814,
"ema21": 26.368012585664452,
"ema50": 26.071667195051063,
"ema200": 24.10000328978518,
"ema10": 26.07539274328305,
"ema20": 26.357207701912515,
"ema10_slope_pct": -0.98,
"ema20_slope_pct": -0.97,
"trend_dir": "down",
"checks": {
"price_above_all": false,
"ema_stacked": false,
"ema21_rising": false,
"ema50_rising": true,
"adx_over_30": false,
"higher_highs_lows": false,
"lower_highs_lows": true,
"near_21ema": false
},
"dist_21ema_pct": -4.7,
"macd": {
"macd": -0.247,
"signal": -0.119,
"histogram": -0.129
},
"bollinger": {
"mid": 26.57,
"upper": 28.37,
"lower": 24.76,
"width_pct": 13.61
},
"crossover": {
"fresh_cross": null,
"pre_compressed": null,
"held_above_21": null,
"candles_since": null,
"intraday_support": false
},
"momentum": {
"roc10": -4.9,
"ret_3d": -1.85,
"ret_5d": -2.69,
"roc10_accel": 2.82,
"checks": {
"roc_over_5": false,
"rsi_in_band": false,
"macd_expanding": false,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": false
},
"volume": {
"rvol": 0.98,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": false,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": false,
"last_up_beats_down": true
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 7.02,
"checks": {
"beats_spy_all": false,
"beats_sector_10d": false,
"rs_line_at_high": false,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"avg_vol_over_2m": false,
"mcap_over_1b": true,
"no_earnings_7d": true,
"not_lev_etf_spac": true,
"bidask_spread": null,
"dollar_vol_over_10m": true
},
"avg_dollar_vol": 42297265.22,
"avg_vol": 1678796
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": true,
"iv_contracting": false,
"oi_calls_above_price": false
},
"vals": {
"call_vol_mult": 0.0,
"iv_rank": 29.0
}
}
}
}
Data:
{
"prior_day": {
"high": 26.56,
"low": 24.88,
"close": 25.18,
"date": "2026-08-20"
},
"woodie_pivots": {
"PP": 25.45,
"R1": 26.02,
"S1": 24.35,
"R2": 27.13,
"S2": 23.77
},
"swing": {
"high_20d": 29.24,
"low_20d": 24.76,
"high_60d": 29.84,
"low_60d": 20.48
},
"orb": {
"high": 26.56,
"low": 25.81,
"date": "2026-08-20"
},
"vwap": 25.18,
"volume_profile": {
"poc": 26.06,
"vah": 26.97,
"val": 25.47,
"sessions": 20
},
"premarket": {
"date": "2026-08-20",
"high": 27,
"low": 26.44,
"last": 26.44,
"volume": 502,
"gap_pct": -0.08,
"path": "07:25 27.00 -> 08:40 26.44",
"bars": 2,
"last_bar_et": "08:40"
},
"recent_daily": [
{
"d": "2026-07-17",
"o": 27.49,
"h": 28.87,
"l": 27.425,
"c": 28.49,
"v": 1265376.825456
},
{
"d": "2026-07-20",
"o": 28.54,
"h": 28.98,
"l": 27.5,
"c": 27.53,
"v": 1254200.09452
},
{
"d": "2026-07-21",
"o": 27.53,
"h": 28.5,
"l": 27.52,
"c": 28.26,
"v": 1370446.046586
},
{
"d": "2026-07-22",
"o": 28.05,
"h": 28.4607,
"l": 27.69,
"c": 27.9,
"v": 802453.498104
},
{
"d": "2026-07-23",
"o": 27.3,
"h": 27.931,
"l": 26.985,
"c": 27.33,
"v": 1031412.940625
},
{
"d": "2026-07-24",
"o": 27.5,
"h": 27.69,
"l": 26.78,
"c": 27.35,
"v": 819355.901916
},
{
"d": "2026-07-27",
"o": 27.62,
"h": 28.6,
"l": 27.54,
"c": 27.84,
"v": 1199084.334984
},
{
"d": "2026-07-28",
"o": 28.09,
"h": 28.53,
"l": 27.51,
"c": 28.42,
"v": 1066059.918443
},
{
"d": "2026-07-29",
"o": 28.18,
"h": 28.525,
"l": 27.72,
"c": 27.86,
"v": 977252.079765
},
{
"d": "2026-07-30",
"o": 28.01,
"h": 28.14,
"l": 27.33,
"c": 27.99,
"v": 1266701.523995
},
{
"d": "2026-07-31",
"o": 27.77,
"h": 27.965,
"l": 26.315,
"c": 26.86,
"v": 1548716.831242
},
{
"d": "2026-08-03",
"o": 26.67,
"h": 26.855,
"l": 25.63,
"c": 25.94,
"v": 1570530.789839
},
{
"d": "2026-08-04",
"o": 26.07,
"h": 26.405,
"l": 25.835,
"c": 26.03,
"v": 1939087.923962
},
{
"d": "2026-08-05",
"o": 26.07,
"h": 27.11,
"l": 26.06,
"c": 27.1,
"v": 2448788.353214
},
{
"d": "2026-08-06",
"o": 29.21,
"h": 29.24,
"l": 26.23,
"c": 26.43,
"v": 3264375.583904
},
{
"d": "2026-08-07",
"o": 26.65,
"h": 26.88,
"l": 25.265,
"c": 25.29,
"v": 2449133.167454
},
{
"d": "2026-08-10",
"o": 24.93,
"h": 25.95,
"l": 24.76,
"c": 25.92,
"v": 2094918.895805
},
{
"d": "2026-08-11",
"o": 26.24,
"h": 26.82,
"l": 25.82,
"c": 26.23,
"v": 1050003.931402
},
{
"d": "2026-08-12",
"o": 26.62,
"h": 26.62,
"l": 25.92,
"c": 26.28,
"v": 1184073.406274
},
{
"d": "2026-08-13",
"o": 26.57,
"h": 26.65,
"l": 25.765,
"c": 25.83,
"v": 1585686.792456
},
{
"d": "2026-08-14",
"o": 25.39,
"h": 26.235,
"l": 25.28,
"c": 26.19,
"v": 1109513.385759
},
{
"d": "2026-08-17",
"o": 26.2,
"h": 26.341,
"l": 25.51,
"c": 25.61,
"v": 1710163.372611
},
{
"d": "2026-08-18",
"o": 25.51,
"h": 26.71,
"l": 25.49,
"c": 26.54,
"v": 1972077.686213
},
{
"d": "2026-08-19",
"o": 27,
"h": 27.19,
"l": 26.37,
"c": 26.46,
"v": 1025411.289514
},
{
"d": "2026-08-20",
"o": 26.5,
"h": 26.56,
"l": 24.8802,
"c": 25.185,
"v": 1589225.234132
}
]
}
Data:
{
"estimates": [
{
"symbol": "ARQT",
"date": "2030-12-31",
"revenueLow": 1027286482,
"revenueHigh": 1121602915,
"revenueAvg": 1069503667,
"ebitdaLow": -347960332,
"ebitdaHigh": -318700086,
"ebitdaAvg": -331797329,
"ebitLow": -354127991,
"ebitHigh": -324349101,
"ebitAvg": -337678495,
"netIncomeLow": 354872169,
"netIncomeHigh": 397756389,
"netIncomeAvg": 374067962,
"sgaExpenseLow": 8040609589,
"sgaExpenseHigh": 8778827826,
"sgaExpenseAvg": 8371045070,
"epsAvg": 2.94,
"epsHigh": 3.12618,
"epsLow": 2.78913,
"numAnalystsRevenue": 6,
"numAnalystsEps": 2
},
{
"symbol": "ARQT",
"date": "2029-12-31",
"revenueLow": 896392350,
"revenueHigh": 978691232,
"revenueAvg": 933230333,
"ebitdaLow": -303624145,
"ebitdaHigh": -278092162,
"ebitdaAvg": -289520589,
"ebitLow": -309005937,
"ebitHigh": -283021395,
"ebitAvg": -294652393,
"netIncomeLow": 304780143,
"netIncomeHigh": 341610569,
"netIncomeAvg": 321265852,
"sgaExpenseLow": 7016096338,
"sgaExpenseHigh": 7660252756,
"sgaExpenseAvg": 7304428604,
"epsAvg": 2.525,
"epsHigh": 2.6849,
"epsLow": 2.39543,
"numAnalystsRevenue": 6,
"numAnalystsEps": 3
},
{
"symbol": "ARQT",
"date": "2028-12-31",
"revenueLow": 729035399,
"revenueHigh": 875356216,
"revenueAvg": 794788983,
"ebitdaLow": -271566020,
"ebitdaHigh": -226172200,
"ebitdaAvg": -246571255,
"ebitLow": -276379576,
"ebitHigh": -230181143,
"ebitAvg": -250941774,
"netIncomeLow": 150679410,
"netIncomeHigh": 359516210,
"netIncomeAvg": 276230380,
"sgaExpenseLow": 5706187244,
"sgaExpenseHigh": 6851445733,
"sgaExpenseAvg": 6220842997,
"epsAvg": 1.89761,
"epsHigh": 2.82563,
"epsLow": 1.18427,
"numAnalystsRevenue": 8,
"numAnalystsEps": 6
},
{
"symbol": "ARQT",
"date": "2027-12-31",
"revenueLow": 642538418,
"revenueHigh": 682641056,
"revenueAvg": 662584587,
"ebitdaLow": -211779058,
"ebitdaHigh": -199337821,
"ebitdaAvg": -205556842,
"ebitLow": -215532879,
"ebitHigh": -202871119,
"ebitAvg": -209200373,
"netIncomeLow": 125106648,
"netIncomeHigh": 197953203,
"netIncomeAvg": 154993350,
"sgaExpenseLow": 5029172149,
"sgaExpenseHigh": 5343056992,
"sgaExpenseAvg": 5186074261,
"epsAvg": 1.19487,
"epsHigh": 1.55582,
"epsLow": 0.98328,
"numAnalystsRevenue": 6,
"numAnalystsEps": 5
}
],
"price_target": {
"symbol": "ARQT",
"targetHigh": 38,
"targetLow": 34,
"targetConsensus": 36.67,
"targetMedian": 38
},
"ratings": {
"symbol": "ARQT",
"rating": "C+",
"overallScore": 2,
"discountedCashFlowScore": 1,
"returnOnEquityScore": 4,
"returnOnAssetsScore": 4,
"debtToEquityScore": 2,
"priceToEarningsScore": 1,
"priceToBookScore": 1
},
"grades": [
{
"symbol": "ARQT",
"date": "2026-08-06",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARQT",
"date": "2026-08-06",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "ARQT",
"date": "2026-08-06",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARQT",
"date": "2026-05-07",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARQT",
"date": "2026-03-02",
"gradingCompany": "Mizuho",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "ARQT",
"date": "2026-02-27",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARQT",
"date": "2026-02-26",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARQT",
"date": "2026-02-26",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARQT",
"date": "2026-02-26",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARQT",
"date": "2026-01-26",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ARQT",
"date": "2025-11-28",
"gradingCompany": "Mizuho",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "ARQT",
"date": "2025-10-30",
"gradingCompany": "Goldman Sachs",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "ARQT",
"date": "2025-10-28",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
}
]
}
Data:
[
{
"title": "Arcutis President and CEO Todd Watanabe Sells 4,375 Shares for $114,275 as Q2 Results Demonstrate Profitability",
"url": "https://www.fool.com/coverage/filings/2026/08/06/arcutis-president-and-ceo-todd-watanabe-sells-4-375-shares-for-usd114-275-as-q2-results-demonstrate-profitability/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-08-06T12:30:01Z",
"summary": "Arcutis Biotherapeutics CEO Todd Watanabe sold 4,375 shares for $114,275 on August 3, 2026, to cover tax withholding obligations on vesting restricted stock units. The sale is non-discretionary and does not signal a change in management sentiment. Meanwhile, Arcutis reported stro",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F1a599f395be31e2f508c3aa7decb988f9ce983b7-1401x1251.png%3Fw%3D800%26q%3D75%26fit%3Dmax%26auto%3Dformat&w=1200&op=resize"
},
{
"title": "Arcutis Biotherapeutics, Inc. (ARQT) Q2 2026 Earnings Call Transcript",
"url": "https://seekingalpha.com/article/4931367-arcutis-biotherapeutics-inc-arqt-q2-2026-earnings-call-transcript",
"source": "Seeking Alpha",
"date": "2026-08-05 22:00:04",
"summary": "Arcutis Biotherapeutics, Inc. (ARQT) Q2 2026 Earnings Call Transcript",
"image": "https://images.financialmodelingprep.com/news/arcutis-biotherapeutics-inc-arqt-q2-2026-earnings-call-transcript-20260805.jpg"
},
{
"title": "Arcutis Biotherapeutics, Inc. (ARQT) Q2 Earnings and Revenues Surpass Estimates",
"url": "https://www.zacks.com/stock/news/2969130/arcutis-biotherapeutics-inc-arqt-q2-earnings-and-revenues-surpass-estimates?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|yseop_template_4-2969130",
"source": "Zacks Investment Research",
"date": "2026-08-05 18:11:04",
"summary": "Arcutis Biotherapeutics, Inc. (ARQT) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to a loss of $0.13 per share a year ago.",
"image": "https://images.financialmodelingprep.com/news/arcutis-biotherapeutics-inc-arqt-q2-earnings-and-revenues-surpass-20260805.jpg"
},
{
"title": "Arcutis Biotherapeutics Q2 Earnings Call Highlights",
"url": "https://www.marketbeat.com/instant-alerts/arcutis-biotherapeutics-q2-earnings-call-highlights-2026-08-05/",
"source": "MarketBeat",
"date": "2026-08-05 18:05:22",
"summary": "Arcutis Biotherapeutics NASDAQ: ARQT reported second-quarter 2026 net product revenue of $129.9 million, up 59% from the prior-year period and 23% sequentially, as demand for its ZORYVE topical treatments continued to rise across approved dermatology indications.",
"image": "https://images.financialmodelingprep.com/news/arcutis-biotherapeutics-q2-earnings-call-highlights-20260805.jpg"
},
{
"title": "Arcutis Announces Second Quarter 2026 Financial Results and Provides Business Update",
"url": "https://www.globenewswire.com/news-release/2026/08/05/3339629/0/en/Arcutis-Announces-Second-Quarter-2026-Financial-Results-and-Provides-Business-Update.html",
"source": "GlobeNewsWire",
"date": "2026-08-05 16:00:00",
"summary": "Continued strong ZORYVE\u00ae (roflumilast) net product revenue growth, with Q2 revenues of $129.9 million, +59% versus Q2 of 2025, and +23% versus Q1 of 2026, driven primarily by strong demand growth Company raising 2026 full-year net product sales guidance to $525 million\u2013$540 milli",
"image": "https://images.financialmodelingprep.com/news/arcutis-announces-second-quarter-2026-financial-results-and-provides-20260805.jpg"
},
{
"title": "4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates",
"url": "https://www.zacks.com/stock/news/2966652/4-biotech-stocks-likely-to-outpace-q2-earnings-estimates?cid=CS-STOCKNEWSAPI-FT-earnings_esp-2966652",
"source": "Zacks Investment Research",
"date": "2026-08-03 11:35:25",
"summary": "Medical sector earnings are off to a strong start, and four biotech companies are positioned to potentially beat estimates in upcoming quarterly results.",
"image": "https://images.financialmodelingprep.com/news/4-biotech-stocks-likely-to-outpace-q2-earnings-estimates-20260803.jpg"
},
{
"title": "Arcutis Biotherapeutics, Inc. (ARQT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release",
"url": "https://www.zacks.com/stock/news/2963251/arcutis-biotherapeutics-inc-arqt-earnings-expected-to-grow-what-to-know-ahead-of-next-week-s-release?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_9-2963251",
"source": "Zacks Investment Research",
"date": "2026-07-29 11:06:18",
"summary": "Arcutis Biotherapeutics (ARQT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
"image": "https://images.financialmodelingprep.com/news/arcutis-biotherapeutics-inc-arqt-earnings-expected-to-grow-what-20260729.jpg"
},
{
"title": "Wall Street Analysts Think Arcutis Biotherapeutics (ARQT) Could Surge 25.79%: Read This Before Placing a Bet",
"url": "https://www.zacks.com/stock/news/2957225/wall-street-analysts-think-arcutis-biotherapeutics-arqt-could-surge-25-79-read-this-before-placing-a-bet?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|consensus_price_target-2957225",
"source": "Zacks Investment Research",
"date": "2026-07-21 10:55:17",
"summary": "The mean of analysts' price targets for Arcutis Biotherapeutics (ARQT) points to a 25.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the st",
"image": "https://images.financialmodelingprep.com/news/wall-street-analysts-think-arcutis-biotherapeutics-arqt-could-surge-20260721.jpg"
},
{
"title": "Arcutis Expands Board of Directors with Appointment of Chris Peetz",
"url": "https://www.globenewswire.com/news-release/2026/07/16/3328471/0/en/Arcutis-Expands-Board-of-Directors-with-Appointment-of-Chris-Peetz.html",
"source": "GlobeNewswire Inc.",
"date": "2026-07-16T13:00:00Z",
"summary": "Arcutis Biotherapeutics announced the appointment of Christopher Peetz, CEO of Mirum Pharmaceuticals, to its Board of Directors effective July 15, 2026. Peetz brings extensive biopharmaceutical leadership experience from roles at multiple companies including Onyx Pharmaceuticals ",
"image": "https://ml.globenewswire.com/Resource/Download/38f7299d-ce17-4941-8ba3-51355332de12"
},
{
"title": "Arcutis to Report Second Quarter 2026 Financial Results and Host Conference Call on August 5, 2026",
"url": "https://www.globenewswire.com/news-release/2026/07/15/3328077/0/en/Arcutis-to-Report-Second-Quarter-2026-Financial-Results-and-Host-Conference-Call-on-August-5-2026.html",
"source": "GlobeNewsWire",
"date": "2026-07-15 16:00:00",
"summary": "WESTLAKE VILLAGE, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. \u00a0(Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will report its second quarter 2026 ",
"image": "https://images.financialmodelingprep.com/news/arcutis-to-report-second-quarter-2026-financial-results-and-20260715.jpg"
},
{
"title": "Biotech Stock Arcutis Climbs Into Buy Zone As FDA Mulls Expanded Use For Key Skin Treatment",
"url": "https://www.investors.com/research/biotech-stock-arcutis-biotherapeutics-arqt-skin-dermatology-health-markets-investing/",
"source": "Investors Business Daily",
"date": "2026-07-09 13:37:04",
"summary": "Biotech stock Arcutis is in a buy zone and Wall Street is looking for the skin-diseases drugmaker to expand the use of its key cream, Zorvye.",
"image": "https://images.financialmodelingprep.com/news/biotech-stock-arcutis-climbs-into-buy-zone-as-fda-20260709.jpg"
},
{
"title": "FDA Accepts Supplemental New Drug Application for Arcutis' ZORYVE\u00ae (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months",
"url": "https://www.globenewswire.com/news-release/2026/07/08/3324020/0/en/fda-accepts-supplemental-new-drug-application-for-arcutis-zoryve-roflumilast-cream-0-05-for-the-treatment-of-mild-to-moderate-atopic-dermatitis-in-infants-down-to-3-months.html",
"source": "GlobeNewsWire",
"date": "2026-07-08 08:00:00",
"summary": "FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027 Application supported by positive results from Phase 2 open-label INTEGUMENT-INFANT study and Phase 1 open-label pharmacokinetic (PK) study 1 million children under the age of 2 are treat",
"image": "https://images.financialmodelingprep.com/news/fda-accepts-supplemental-new-drug-application-for-arcutis-zoryve-20260708.jpg"
},
{
"title": "Arcutis vs. Vertex: Which Pharmaceutical Maker Stock Is a Better Buy in 2026?",
"url": "https://www.fool.com/coverage/better-buy/2026/07/03/arcutis-vs-vertex-which-pharmaceutical-maker-stock-is-a-better-buy-in-2026/",
"source": "Fool - Investing News",
"date": "2026-07-03 08:37:20",
"summary": "Arcutis doubled revenue last year while Vertex delivered strong profits and cash flow. Explore how each company stacks up on growth, risk, and value.",
"image": "https://images.financialmodelingprep.com/news/arcutis-vs-vertex-which-pharmaceutical-maker-stock-is-a-20260703.png"
},
{
"title": "FDA Approves Arcutis\u2019 ZORYVE\u00ae (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2",
"url": "https://www.globenewswire.com/news-release/2026/06/29/3319348/0/en/FDA-Approves-Arcutis-ZORYVE-roflumilast-Cream-0-3-for-the-Treatment-of-Plaque-Psoriasis-in-Children-as-Young-as-Age-2.html",
"source": "GlobeNewswire Inc.",
"date": "2026-06-29T23:06:00Z",
"summary": "The FDA has approved ZORYVE cream 0.3% for treating plaque psoriasis in children as young as age 2, marking the first once-daily, non-steroidal therapy for this indication. This is Arcutis' seventh FDA approval for ZORYVE in four years. The approval addresses a significant treatm",
"image": "https://ml.globenewswire.com/Resource/Download/1b166f47-afb1-44f1-91be-2d73e97c0ec3"
},
{
"title": "Arcutis Director Sells $121,000 in Stock as ZORYVE Revenue Jumps 65%",
"url": "https://www.fool.com/coverage/filings/2026/06/23/arcutis-director-sells-usd121-000-in-stock-as-zoryve-revenue-jumps-65/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-06-23T23:15:13Z",
"summary": "Arcutis Biotherapeutics director Sue-Jean Lin sold 4,946 shares worth $121,000 on June 15, 2026, under a pre-arranged trading plan. The sale reduced her stake by 15% but she retains over 27,500 shares. The insider transaction appears routine amid strong company performance, with ",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F5a835a403d8e07011d119675ff444b39fb510d2f-1401x1251.png%3Fw%3D800%26q%3D75%26fit%3Dmax%26auto%3Dformat&w=1200&op=resize"
},
{
"title": "Antag Therapeutics Elects Keith Leonard as Chairman of its Board of Directors",
"url": "https://www.globenewswire.com/news-release/2026/06/09/3308675/0/en/Antag-Therapeutics-Elects-Keith-Leonard-as-Chairman-of-its-Board-of-Directors.html",
"source": "GlobeNewswire Inc.",
"date": "2026-06-09T11:00:00Z",
"summary": "Antag Therapeutics announced the election of Keith Leonard as Chairman of its Board of Directors. Leonard brings 30 years of biopharmaceutical industry experience, including previous roles as Chairman and CEO of Unity Biotechnology and co-founder/CEO of Kythera Biopharmaceuticals",
"image": "https://ml-eu.globenewswire.com/Resource/Download/5001e437-9bc0-482c-9bee-3be9c9f71505"
},
{
"title": "Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)",
"url": "https://www.globenewswire.com/news-release/2026/06/05/3307595/0/en/Arcutis-Biotherapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html",
"source": "GlobeNewswire Inc.",
"date": "2026-06-05T20:00:00Z",
"summary": "Arcutis Biotherapeutics granted an aggregate of 44,000 restricted stock units to six newly hired employees as a material inducement for employment. The RSUs vest over four years with 25% vesting annually, subject to continuous employment. The grants were approved by the Compensat",
"image": "https://ml.globenewswire.com/Resource/Download/1b166f47-afb1-44f1-91be-2d73e97c0ec3"
},
{
"title": "Arcutis Management to Present at Goldman Sachs 47th Annual Global Healthcare Conference",
"url": "https://www.globenewswire.com/news-release/2026/05/26/3301430/0/en/Arcutis-Management-to-Present-at-Goldman-Sachs-47th-Annual-Global-Healthcare-Conference.html",
"source": "GlobeNewswire Inc.",
"date": "2026-05-26T20:00:00Z",
"summary": "Arcutis Biotherapeutics announced that management will present at the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026, in Miami. The commercial-stage biopharmaceutical company, focused on immuno-dermatology innovations, will participate in a fireside chat. ",
"image": "https://ml.globenewswire.com/Resource/Download/1b166f47-afb1-44f1-91be-2d73e97c0ec3"
},
{
"title": "Arcutis Announces First Quarter 2026 Financial Results and Provides Business Update",
"url": "https://www.globenewswire.com/news-release/2026/05/06/3289285/0/en/Arcutis-Announces-First-Quarter-2026-Financial-Results-and-Provides-Business-Update.html",
"source": "GlobeNewswire Inc.",
"date": "2026-05-06T20:00:00Z",
"summary": "Arcutis Biotherapeutics reported Q1 2026 net product revenue of $105.4 million for ZORYVE (roflumilast), representing 65% year-over-year growth despite 17% sequential decline due to typical Q1 seasonality. The company submitted a supplemental New Drug Application to expand ZORYVE",
"image": "https://ml.globenewswire.com/Resource/Download/1b166f47-afb1-44f1-91be-2d73e97c0ec3"
},
{
"title": "Arcutis to Report First Quarter 2026 Financial Results and Host Conference Call on May 6, 2026",
"url": "https://www.globenewswire.com/news-release/2026/04/15/3274854/0/en/Arcutis-to-Report-First-Quarter-2026-Financial-Results-and-Host-Conference-Call-on-May-6-2026.html",
"source": "GlobeNewswire Inc.",
"date": "2026-04-15T20:00:00Z",
"summary": "Arcutis Biotherapeutics announced it will report first quarter 2026 financial results on May 6, 2026, followed by a conference call at 4:30pm ET. The company also presented new Phase 2 results in infants with atopic dermatitis at the 2026 American Academy of Dermatology Annual Me",
"image": "https://ml.globenewswire.com/Resource/Download/1b166f47-afb1-44f1-91be-2d73e97c0ec3"
},
{
"title": "Arcutis Stock Up 65% as Director Sells 10,000 Shares Under 10b5-1 Plan. Here's What Investors Should Know",
"url": "https://www.fool.com/coverage/filings/2026/04/08/arcutis-stock-up-65-as-director-sells-10-000-shares-under-10b5-1-plan-here-s-what-investors-should-know/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-04-08T11:30:19Z",
"summary": "Arcutis Biotherapeutics director Howard G. Welgus sold 10,000 shares worth $239,000 on April 1, 2026, under a pre-planned 10b5-1 trading plan adopted in March 2025. The sale represents a routine liquidity event rather than a loss of confidence, as the company's stock has surged 6",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F5a835a403d8e07011d119675ff444b39fb510d2f-1401x1251.png%3Fw%3D800%26q%3D75%26fit%3Dmax%26auto%3Dformat&w=1200&op=resize"
},
{
"title": "Arcutis Management to Present at TD Cowen\u2019s 46th Annual Health Care Conference",
"url": "https://www.globenewswire.com/news-release/2026/02/27/3246782/0/en/Arcutis-Management-to-Present-at-TD-Cowen-s-46th-Annual-Health-Care-Conference.html",
"source": "GlobeNewswire Inc.",
"date": "2026-02-27T21:00:00Z",
"summary": "Arcutis Biotherapeutics announced its Q4 and full year 2025 financial results and provided a business update. The company will present at the TD Cowen 46th Annual Health Care Conference on March 2-4, 2026, in Boston. Arcutis also announced that professional golfer Max Homa has jo",
"image": "https://ml.globenewswire.com/Resource/Download/1b166f47-afb1-44f1-91be-2d73e97c0ec3"
},
{
"title": "Arcutis Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update",
"url": "https://www.globenewswire.com/news-release/2026/02/25/3244953/0/en/Arcutis-Announces-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html",
"source": "GlobeNewswire Inc.",
"date": "2026-02-25T21:00:00Z",
"summary": "Arcutis Biotherapeutics reported Q4 2025 net product revenue of $127.5 million for ZORYVE (roflumilast), an 84% increase year-over-year, with full-year 2025 revenue reaching $372.1 million (123% growth). The company achieved positive operating cash flow, raised 2026 guidance to $",
"image": "https://ml.globenewswire.com/Resource/Download/1b166f47-afb1-44f1-91be-2d73e97c0ec3"
},
{
"title": "This Biopharma Stock Has Surged Nearly 100% and One Fund Just Locked in Gains With a $10 Million Exit",
"url": "https://www.fool.com/coverage/filings/2026/02/06/this-biopharma-stock-has-surged-nearly-100-and-one-fund-just-locked-in-gains-with-a-usd10-million-exit/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-02-06T10:18:00Z",
"summary": "Tejara Capital exited its entire position in Arcutis Biotherapeutics, selling 520,503 shares for approximately $9.81 million in February 2026. The stock has surged 99.1% over the past year, driven by strong Q3 results showing net product revenue more than doubling year-over-year.",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F5a835a403d8e07011d119675ff444b39fb510d2f-1401x1251.png%3Fw%3D1401%26h%3D1251&w=1200&op=resize"
}
]
Data:
[
{
"symbol": "ARQT",
"date": "2026-10-27",
"epsActual": null,
"epsEstimated": 0.17,
"revenueActual": null,
"revenueEstimated": 141015900,
"lastUpdated": "2026-08-20"
},
{
"symbol": "ARQT",
"date": "2026-08-05",
"epsActual": 0.11,
"epsEstimated": 0.05508,
"revenueActual": 129861000,
"revenueEstimated": 118852300,
"lastUpdated": "2026-08-20"
},
{
"symbol": "ARQT",
"date": "2026-05-06",
"epsActual": -0.09,
"epsEstimated": -0.02,
"revenueActual": 105398000,
"revenueEstimated": 103675300,
"lastUpdated": "2026-08-06"
},
{
"symbol": "ARQT",
"date": "2026-02-25",
"epsActual": 0.13,
"epsEstimated": 0.03,
"revenueActual": 129503000,
"revenueEstimated": 113055100,
"lastUpdated": "2026-05-25"
},
{
"symbol": "ARQT",
"date": "2025-10-28",
"epsActual": 0.06,
"epsEstimated": -0.1,
"revenueActual": 99219000,
"revenueEstimated": 110794170,
"lastUpdated": "2026-01-28"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "ARQT",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "ARQT",
"periods": [
{
"file_period": "202604a",
"settlement_date": "20260414",
"quantity_fails": 462,
"price": 24.12
},
{
"file_period": "202604b",
"settlement_date": "20260430",
"quantity_fails": 57,
"price": 22.37
},
{
"file_period": "202606a",
"settlement_date": "20260611",
"quantity_fails": 797,
"price": 23.23
},
{
"file_period": "202606b",
"settlement_date": "20260629",
"quantity_fails": 361,
"price": 27.0
},
{
"file_period": "202607b",
"settlement_date": "20260729",
"quantity_fails": 6,
"price": 28.42
}
],
"trend": "falling",
"trend_description": "FTD quantity declining \u2014 shorts covering or delivery improving"
}
}
Data:
{
"insider": [
{
"symbol": "ARQT",
"filingDate": "2026-08-19",
"transactionDate": "2026-08-17",
"reportingCik": "0001801050",
"companyCik": "0001787306",
"transactionType": "M-Exempt",
"securitiesOwned": 41205,
"reportingName": "Welgus Howard G.",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 2255,
"price": 8.63,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1787306/000162828026058008/0001628280-26-058008-index.htm"
},
{
"symbol": "ARQT",
"filingDate": "2026-08-19",
"transactionDate": "2026-08-17",
"reportingCik": "0001801050",
"companyCik": "0001787306",
"transactionType": "M-Exempt",
"securitiesOwned": 38950,
"reportingName": "Welgus Howard G.",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 1019,
"price": 7.51,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1787306/000162828026058008/0001628280-26-058008-index.htm"
},
{
"symbol": "ARQT",
"filingDate": "2026-08-19",
"transactionDate": "2026-08-17",
"reportingCik": "0001801050",
"companyCik": "0001787306",
"transactionType": "M-Exempt",
"securitiesOwned": 37931,
"reportingName": "Welgus Howard G.",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 822,
"price": 6.5223,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1787306/000162828026058008/0001628280-26-058008-index.htm"
},
{
"symbol": "ARQT",
"filingDate": "2026-08-19",
"transactionDate": "2026-08-17",
"reportingCik": "0001801050",
"companyCik": "0001787306",
"transactionType": "S-Sale",
"securitiesOwned": 36475,
"reportingName": "Welgus Howard G.",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 4730,
"price": 26.1807,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1787306/000162828026058008/0001628280-26-058008-index.htm"
},
{
"symbol": "ARQT",
"filingDate": "2026-08-19",
"transactionDate": "2026-08-17",
"reportingCik": "0001801050",
"companyCik": "0001787306",
"transactionType": "M-Exempt",
"securitiesOwned": 20287,
"reportingName": "Welgus Howard G.",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 2255,
"price": 8.63,
"securityName": "Stock Option (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1787306/000162828026058008/0001628280-26-058008-index.htm"
},
{
"symbol": "ARQT",
"filingDate": "2026-08-19",
"transactionDate": "2026-08-17",
"reportingCik": "0001801050",
"companyCik": "0001787306",
"transactionType": "M-Exempt",
"securitiesOwned": 9163,
"reportingName": "Welgus Howard G.",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 1019,
"price": 7.51,
"securityName": "Stock Option (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1787306/000162828026058008/0001628280-26-058008-index.htm"
},
{
"symbol": "ARQT",
"filingDate": "2026-08-19",
"transactionDate": "2026-08-17",
"reportingCik": "0001801050",
"companyCik": "0001787306",
"transactionType": "M-Exempt",
"securitiesOwned": 7396,
"reportingName": "Welgus Howard G.",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 822,
"price": 6.5223,
"securityName": "Stock Option (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1787306/000162828026058008/0001628280-26-058008-index.htm"
},
{
"symbol": "ARQT",
"filingDate": "2026-08-13",
"transactionDate": "2026-08-11",
"reportingCik": "0001741987",
"companyCik": "0001787306",
"transactionType": "M-Exempt",
"securitiesOwned": 135450,
"reportingName": "Burnett Patrick",
"typeOfOwner": "officer: See Remarks",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 8300,
"price": 3.64,
"securityName": "Stock Option (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1787306/000162828026056898/0001628280-26-056898-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
{
"symbol": "ARQT",
"senateID": "C001123",
"disclosureDate": "2026-06-09",
"transactionDate": "2026-05-29",
"firstName": "Gilbert",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "ARCUTIS BIOTHERAPEUTICS INC",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20034713.pdf"
},
{
"symbol": "ARQT",
"senateID": "C001123",
"disclosureDate": "2026-04-08",
"transactionDate": "2026-03-03",
"firstName": "Gilbert",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "ARCUTIS BIOTHERAPEUTICS INC",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20034285.pdf"
},
{
"symbol": "ARQT",
"senateID": "C001123",
"disclosureDate": "2026-01-12",
"transactionDate": "2025-12-11",
"firstName": "Gilbert",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "Arcutis Biotherapeutics, Inc. - Common stock",
"assetType": "Stock",
"type": "Sale (Partial)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20033762.pdf"
},
{
"symbol": "ARQT",
"senateID": "G000583",
"disclosureDate": "2023-10-15",
"transactionDate": "2023-09-15",
"firstName": "Josh",
"lastName": "Gottheimer",
"office": "Josh Gottheimer",
"district": "NJ05",
"owner": "Joint",
"assetDescription": "ARCUTIS BIOTHERAPEUTICS INC",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20023833.pdf"
},
{
"symbol": "ARQT",
"senateID": "G000583",
"disclosureDate": "2023-05-19",
"transactionDate": "2023-04-17",
"firstName": "Josh",
"lastName": "Gottheimer",
"office": "Josh Gottheimer",
"district": "NJ05",
"owner": "Joint",
"assetDescription": "ARCUTIS BIOTHERAPEUTICS INC",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20022877.pdf"
},
{
"symbol": "ARQT",
"senateID": "G000583",
"disclosureDate": "2022-07-22",
"transactionDate": "2022-06-15",
"firstName": "Josh",
"lastName": "Gottheimer",
"office": "Josh Gottheimer",
"district": "NJ05",
"owner": "Joint",
"assetDescription": "Arcutis Biotherapeutics, Inc. - Common stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/20021351.pdf"
}
],
"dark_pool": [
{
"ticker": "ARQT",
"executed_at": "2026-08-20T16:40:29.769000Z",
"size": 13810.0,
"price": 25.15,
"premium": 347321.5,
"volume": 13810.0,
"trade_code": " "
},
{
"ticker": "ARQT",
"executed_at": "2026-08-20T16:40:29.767000Z",
"size": 700.0,
"price": 25.15,
"premium": 17605.0,
"volume": 700.0,
"trade_code": " "
},
{
"ticker": "ARQT",
"executed_at": "2026-08-20T16:40:29.746000Z",
"size": 700.0,
"price": 25.15,
"premium": 17605.0,
"volume": 700.0,
"trade_code": " "
},
{
"ticker": "ARQT",
"executed_at": "2026-08-20T16:40:29.744000Z",
"size": 700.0,
"price": 25.15,
"premium": 17605.0,
"volume": 700.0,
"trade_code": " "
},
{
"ticker": "ARQT",
"executed_at": "2026-08-20T16:40:29.741000Z",
"size": 700.0,
"price": 25.15,
"premium": 17605.0,
"volume": 700.0,
"trade_code": " "
},
{
"ticker": "ARQT",
"executed_at": "2026-08-20T16:40:29.740000Z",
"size": 700.0,
"price": 25.15,
"premium": 17605.0,
"volume": 700.0,
"trade_code": " "
},
{
"ticker": "ARQT",
"executed_at": "2026-08-20T16:40:29.740000Z",
"size": 700.0,
"price": 25.15,
"premium": 17605.0,
"volume": 700.0,
"trade_code": " "
},
{
"ticker": "ARQT",
"executed_at": "2026-08-20T16:40:29.740000Z",
"size": 700.0,
"price": 25.15,
"premium": 17605.0,
"volume": 700.0,
"trade_code": " "
}
],
"ats": {
"symbol": "ARQT",
"date": "20260819",
"ats_volume": 0,
"total_volume": 278787,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260819",
"ats_ratio": 0.0
},
{
"date": "20260818",
"ats_ratio": 0.0
},
{
"date": "20260817",
"ats_ratio": 0.0
},
{
"date": "20260814",
"ats_ratio": 0.0
},
{
"date": "20260813",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "ARQT",
"days": [
{
"date": "2026-08-20",
"close": 25.185,
"vwap": 25.18,
"volume": 1589225,
"vwap_discount_pct": -0.02
},
{
"date": "2026-08-19",
"close": 26.46,
"vwap": 26.6,
"volume": 1025411,
"vwap_discount_pct": 0.55
},
{
"date": "2026-08-18",
"close": 26.54,
"vwap": 26.31,
"volume": 1972077,
"vwap_discount_pct": -0.85
},
{
"date": "2026-08-17",
"close": 25.61,
"vwap": 25.78,
"volume": 1710163,
"vwap_discount_pct": 0.67
},
{
"date": "2026-08-14",
"close": 26.19,
"vwap": 25.91,
"volume": 1109513,
"vwap_discount_pct": -1.09
}
],
"avg_vwap_discount_pct": -0.15,
"signal": "Neutral"
},
"options_flow": [],
"net_premium": {
"ticker": "ARQT",
"net_call_premium": "135.00",
"net_put_premium": "0",
"call_premium": "225.00",
"put_premium": "0",
"bullish_premium": "180.00",
"bearish_premium": "45.00",
"put_call_ratio": "0.00000000000000000000",
"iv_rank": "28.6609",
"implied_move_perc": "0.097000",
"gex_ratio": "0.05370948963615427339",
"gex_net_change": "-416.1556",
"gex_call": "48904.8866",
"gex_put": "-2626.6565",
"gex_net": 46278.2301,
"gex_call_delta": "379157.6624",
"gex_put_delta": "-16779.4469",
"gex_date": "2026-08-20"
},
"hot_chains": [
{
"underlying_symbol": "ARQT",
"expires": "2026-09-18",
"open_interest": 3954,
"option_type": "call",
"delta": 0.0993783716176302,
"ask_volume": 0,
"last_price": "0.45",
"implied_volatility": "0.509671410231763",
"gamma": 0.0517950101957759,
"avg_price": "0.45",
"bid_volume": 1,
"nbbo_ask": "3.60",
"strike": "30",
"option_symbol": "ARQT260918C00030000",
"total_premium": "45.00",
"iv": 0.477427622463712,
"volume": 1,
"nbbo_bid": "0.00"
},
{
"underlying_symbol": "ARQT",
"expires": "2026-12-18",
"open_interest": 25,
"option_type": "call",
"delta": 0.325160888234467,
"ask_volume": 1,
"last_price": "1.80",
"implied_volatility": "0.563329235811817",
"gamma": 0.0489976479409475,
"avg_price": "1.80",
"bid_volume": 0,
"nbbo_ask": "3.00",
"strike": "30",
"option_symbol": "ARQT261218C00030000",
"total_premium": "180.00",
"iv": 0.508298526800987,
"volume": 1,
"nbbo_bid": "0.10"
},
{
"underlying_symbol": "ARQT",
"expires": "2027-01-15",
"open_interest": 812,
"option_type": "call",
"delta": 0.909197452562823,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.01377284404323991,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "15",
"option_symbol": "ARQT270115C00015000",
"total_premium": "0",
"iv": 0.739481567409992,
"volume": 0,
"nbbo_bid": null
},
{
"underlying_symbol": "ARQT",
"expires": "2026-08-21",
"open_interest": 601,
"option_type": "call",
"delta": 0.00406599005331498,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.00496723284443696,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "32.5",
"option_symbol": "ARQT260821C00032500",
"total_premium": "0",
"iv": 1.695954118018799,
"volume": 0,
"nbbo_bid": null
},
{
"underlying_symbol": "ARQT",
"expires": "2027-01-15",
"open_interest": 512,
"option_type": "call",
"delta": 0.26012181431794,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.0328547686166422,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "35",
"option_symbol": "ARQT270115C00035000",
"total_premium": "0",
"iv": 0.615272964036499,
"volume": 0,
"nbbo_bid": null
},
{
"underlying_symbol": "ARQT",
"expires": "2027-01-15",
"open_interest": 427,
"option_type": "call",
"delta": 0.35025812948045,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.0458672697821776,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "30",
"option_symbol": "ARQT270115C00030000",
"total_premium": "0",
"iv": 0.503280964738735,
"volume": 0,
"nbbo_bid": null
},
{
"underlying_symbol": "ARQT",
"expires": "2027-01-15",
"open_interest": 355,
"option_type": "call",
"delta": 0.771459448737262,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.0272365593590742,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "20",
"option_symbol": "ARQT270115C00020000",
"total_premium": "0",
"iv": 0.692142220317461,
"volume": 0,
"nbbo_bid": null
},
{
"underlying_symbol": "ARQT",
"expires": "2026-09-18",
"open_interest": 342,
"option_type": "call",
"delta": 0.333648723081626,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.0836008437373705,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "27.5",
"option_symbol": "ARQT260918C00027500",
"total_premium": "0",
"iv": 0.612233346164,
"volume": 0,
"nbbo_bid": null
}
],
"gamma_profile": {
"ticker": "ARQT",
"spot": 25.19,
"date": "2026-08-20",
"flip_point": 12.7,
"net_gex": 46278.23,
"call_walls": [
{
"strike": 30.0,
"gex": 34058.67
},
{
"strike": 27.5,
"gex": 7505.03
},
{
"strike": 32.5,
"gex": 1879.52
}
],
"put_walls": [
{
"strike": 27.5,
"gex": -1221.16
},
{
"strike": 25.0,
"gex": -387.48
},
{
"strike": 22.5,
"gex": -296.98
}
],
"by_strike": [
{
"strike": 2.5,
"call_gex": 0.0,
"put_gex": -0.0,
"net_gex": -0.0
},
{
"strike": 5.0,
"call_gex": 0.0,
"put_gex": -0.01,
"net_gex": -0.01
},
{
"strike": 7.5,
"call_gex": 0.14,
"put_gex": -0.38,
"net_gex": -0.24
},
{
"strike": 10.0,
"call_gex": 4.6,
"put_gex": -0.58,
"net_gex": 4.02
},
{
"strike": 12.5,
"call_gex": 93.42,
"put_gex": -148.71,
"net_gex": -55.29
},
{
"strike": 15.0,
"call_gex": 681.94,
"put_gex": -39.0,
"net_gex": 642.94
},
{
"strike": 17.5,
"call_gex": 67.4,
"put_gex": -263.65,
"net_gex": -196.25
},
{
"strike": 20.0,
"call_gex": 943.49,
"put_gex": -205.83,
"net_gex": 737.66
},
{
"strike": 22.5,
"call_gex": 121.07,
"put_gex": -296.98,
"net_gex": -175.91
},
{
"strike": 25.0,
"call_gex": 1312.96,
"put_gex": -387.48,
"net_gex": 925.49
},
{
"strike": 27.5,
"call_gex": 7505.03,
"put_gex": -1221.16,
"net_gex": 6283.86
},
{
"strike": 30.0,
"call_gex": 34058.67,
"put_gex": -31.45,
"net_gex": 34027.23
},
{
"strike": 32.5,
"call_gex": 1879.52,
"put_gex": -19.74,
"net_gex": 1859.78
},
{
"strike": 35.0,
"call_gex": 1852.39,
"put_gex": -11.67,
"net_gex": 1840.72
},
{
"strike": 37.5,
"call_gex": 0.0,
"put_gex": -0.01,
"net_gex": -0.01
},
{
"strike": 40.0,
"call_gex": 156.12,
"put_gex": -0.01,
"net_gex": 156.12
},
{
"strike": 45.0,
"call_gex": 228.13,
"put_gex": 0.0,
"net_gex": 228.13
}
]
},
"oi_changes": {
"net_call_oi_change": -22,
"net_put_oi_change": 0,
"top": [
{
"strike": "30",
"oi_change": -15,
"type": "call"
},
{
"strike": "30",
"oi_change": -7,
"type": "call"
},
{
"strike": "15",
"oi_change": 0,
"type": "call"
},
{
"strike": "32.5",
"oi_change": 0,
"type": "call"
},
{
"strike": "35",
"oi_change": 0,
"type": "call"
}
]
}
}
Data:
{
"vix": 15.19,
"sp500": 7745.06,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.53,
"hy_spread": 2.67,
"treasury": {
"date": "2026-08-18",
"month1": 3.78,
"month2": 3.82,
"month3": 3.86,
"month6": 3.94,
"year1": 3.99,
"year2": 4.19,
"year3": 4.26,
"year5": 4.37,
"year7": 4.53,
"year10": 4.71,
"year20": 5.28,
"year30": 5.28
},
"events": []
}
Data:
{
"days": 46,
"patterns": [
{
"name": "VWAP Touch",
"count": 46,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 46,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 46,
"pct": 100
},
{
"name": "Woodie Pivot Touch",
"count": 44,
"pct": 96
},
{
"name": "ORB Breakout",
"count": 43,
"pct": 93
},
{
"name": "PDH/PDL Touch",
"count": 40,
"pct": 87
},
{
"name": "Gap Fill",
"count": 36,
"pct": 78
},
{
"name": "Open Retracement",
"count": 27,
"pct": 59
},
{
"name": "Darvas Box",
"count": 18,
"pct": 39
},
{
"name": "High Vol Open",
"count": 7,
"pct": 15
},
{
"name": "Power Hour",
"count": 5,
"pct": 11
}
]
}